TEMECULA, Calif.--(BUSINESS WIRE)--CVAC Systems, Inc. (www.cvacsystems.com) announced today that it has formed a scientific advisory board to investigate the strengths and limitations of the cyclic variations in altitude conditioning (CVAC) process in the management and treatment of diabetes, insulin resistance and metabolic syndrome. Anne L. Friedlander, Ph.D.; Mike Nichols, M.D.; Michael W. Schwartz, M.D.; and Jeffrey D. White, Ph.D., each possessing diverse backgrounds and expertise, represent a multi-faceted approach for the investigation of this complex, deadly epidemic.
